Compare KSPI & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KSPI | MEDP |
|---|---|---|
| Founded | 2008 | 1992 |
| Country | Kazakhstan | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 12.9B |
| IPO Year | 2023 | 2016 |
| Metric | KSPI | MEDP |
|---|---|---|
| Price | $75.63 | $496.51 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 13 |
| Target Price | $104.33 | ★ $498.25 |
| AVG Volume (30 Days) | ★ 504.2K | 258.8K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | ★ 9.70% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 15.28 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.19 |
| Revenue Next Year | $16.62 | $7.75 |
| P/E Ratio | ★ $7.12 | $32.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.59 | $250.05 |
| 52 Week High | $99.11 | $628.92 |
| Indicator | KSPI | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 53.06 | 59.15 |
| Support Level | $73.45 | $489.09 |
| Resistance Level | $77.97 | $501.30 |
| Average True Range (ATR) | 2.34 | 15.29 |
| MACD | 0.35 | 6.30 |
| Stochastic Oscillator | 72.50 | 84.20 |
Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform that connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.